| Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine J Conde, JT Dias, V Grazú, M Moros, PV Baptista, JM de la Fuente Frontiers in chemistry 2, 48, 2014 | 520 | 2014 |
| Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms M Pérez-Hernández, P Del Pino, SG Mitchell, M Moros, G Stepien, ... ACS nano 9 (1), 52-61, 2015 | 385 | 2015 |
| Aggregation effects on the magnetic properties of iron oxide colloids L Gutiérrez, L De la Cueva, M Moros, E Mazarío, S De Bernardo, ... Nanotechnology 30 (11), 112001, 2019 | 180 | 2019 |
| Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle− antibody conjugates S Puertas, P Batalla, M Moros, E Polo, P Del Pino, JM Guisan, V Grazu, ... ACS nano 5 (6), 4521-4528, 2011 | 179 | 2011 |
| Applying the retro‐enantio approach to obtain a peptide capable of overcoming the blood–brain barrier R Prades, B Oller‐Salvia, SM Schwarzmaier, J Selva, M Moros, M Balbi, ... Angewandte Chemie International Edition 54 (13), 3967-3972, 2015 | 177 | 2015 |
| Monosaccharides versus PEG-Functionalized NPs: Influence in the Cellular Uptake M Moros, B Hernaez, E Garet, JT Dias, B Saez, V Grazu, ... ACS nano 6 (2), 1565-1577, 2012 | 176 | 2012 |
| Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a (1-21) NH2 as a reliable strategy for antipseudomonal drugs B Casciaro, M Moros, S Rivera-Fernandez, A Bellelli, JM de la Fuente, ... Acta biomaterialia 47, 170-181, 2017 | 172 | 2017 |
| Effect of surface chemistry and associated protein corona on the long-term biodegradation of iron oxide nanoparticles in vivo G Stepien, M Moros, M Pérez-Hernández, M Monge, L Gutiérrez, ... ACS applied materials & interfaces 10 (5), 4548-4560, 2018 | 160 | 2018 |
| Engineering biofunctional magnetic nanoparticles for biotechnological applications M Moros, B Pelaz, P López-Larrubia, ML García-Martin, V Grazú, ... Nanoscale 2 (9), 1746-1755, 2010 | 149 | 2010 |
| DNA as molecular local thermal probe for magnetic hyperthermia analysis JT Dias, M Moros, P Pino González de la Higuera, S Rivera-Fernández, ... Wiley-VCH, 2013 | 130 | 2013 |
| Magnetic-responsive release controlled by hot spot effect E Guisasola, A Baeza, M Talelli, D Arcos, M Moros, JM de la Fuente, ... Langmuir 31 (46), 12777-12782, 2015 | 129 | 2015 |
| Triggering antitumoural drug release and gene expression by magnetic hyperthermia M Moros, J Idiago-López, L Asín, E Moreno-Antolín, L Beola, V Grazú, ... Advanced drug delivery reviews 138, 326-343, 2019 | 125 | 2019 |
| Synthesis and stealthing study of bare and PEGylated silica micro-and nanoparticles as potential drug-delivery vectors C Yagüe, M Moros, V Grazú, M Arruebo, J Santamaría Chemical Engineering Journal 137 (1), 45-53, 2008 | 113 | 2008 |
| Designing novel nano-immunoassays: antibody orientation versus sensitivity S Puertas, M Moros, R Fernández-Pacheco, MR Ibarra, V Grazú, ... Journal of physics D: applied physics 43 (47), 474012, 2010 | 109 | 2010 |
| Chemical synthesis and magnetic properties of monodisperse nickel ferrite nanoparticles for biomedical applications X Lasheras, M Insausti, I Gil de Muro, E Garaio, F Plazaola, M Moros, ... The Journal of Physical Chemistry C 120 (6), 3492-3500, 2016 | 103 | 2016 |
| Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research M Ramirez-Garrastacho, C Bajo-Santos, A Line, ES Martens-Uzunova, ... British journal of cancer 126 (3), 331-350, 2022 | 83 | 2022 |
| Sterilization matters: consequences of different sterilization techniques on gold nanoparticles A França, B Pelaz, M Moros, C Sánchez‐Espinel, A Hernández, ... small 6 (1), 89-95, 2010 | 82 | 2010 |
| A promising road with challenges: where are gold nanoparticles in translational research? C Bao, J Conde, E Polo, P Del Pino, M Moros, PV Baptista, V Grazu, ... Nanomedicine 9 (15), 2353-2370, 2014 | 77 | 2014 |
| Deciphering Intracellular Events Triggered by Mild Magnetic Hyperthermia in Vitro and in Vivo M Moros, A Ambrosone, G Stepien, F Fabozzi, V Marchesano, A Castaldi, ... Nanomedicine 10 (14), 2167-2183, 2015 | 60 | 2015 |
| The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome M Moros, SG Mitchell, V Grazu, JM Fuente Current Medicinal Chemistry 20 (22), 2759-2778, 2013 | 53 | 2013 |
